mens group

Delivering Men’s Health: A Guide for Policymakers and Service Providers

GAMH’s latest project is to produce a new resource that will fill gaps in evidence and knowledge about how health policymakers and service providers at all levels (global, national and local) can take practical steps to improve men’s health and wellbeing and encourage the development and delivery of policies and programmes that lead to improvements in the health and wellbeing of men.

The new resource will not be a conventional report. Although there will be a report in PDF format, the main output will be a fully searchable online database which will include guidance, background analysis and case-studies. There will also be an extensive bibliography with links. This will be hosted jointly on the GAMH and Mengage websites.

Crucially, to ensure that the report does not become ‘just another’ worthy but ineffective output, GAMH will seek partner organisations that will work with GAMH on implementation of the guidance. This may involve additional fundraising for specific spin-off projects whose outcomes will be fed back into the new GAMH database and in relevant journals and other publications.

GAMH will host at least two webinars to disseminate the report’s findings and opportunities for journal papers will be explored, including in mainstream publications, such as the Bulletin of the World Health Organisation, the Journal of Global Health and Global Public Health.

GAMH will also incorporate the report’s findings into a new online training programme for policymakers and service providers. This programme will also be hosted on the GAMH site and will be delivered with both study-alone and live interactive options.

The project has been funded by an educational grant of EUR 35,000.00 from Advanced Accelerator Applications (AAA), a Novartis company that is developing nuclear medicine treatments for cancer. AAA has neither sought nor had any influence on the project’s design, delivery or findings. The relationship between GAMH and AAA is at all times conducted in line with the ABPI Code of Practice for the Pharmaceutical Industry 2019 and GAMH’s ethical policy which governs its relationships with partner organisations, funders and other stakeholders.

The report will be published in September 2021.

15 July 2021